Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Journal of Biopharmaceutical Statistics
|
February 19, 2024
A basket trial design based on constrained hierarchical Bayesian model for latent subgroups
Kentaro Takeda, Atsuki Hashimoto, Shufang Liu, et al.
The Journal of Chemical Physics
|
May 27, 2026
Classification of interfacial water governed by water-polymer interactions in hydrated polymers: A molecular dynamics simulation study of ethylene-based and acrylate polymers
Atsuki Hashimoto, Kokoro Shikata, Kang Kim, et al.
Journal of Biopharmaceutical Statistics
|
September 17, 2025
BOP2-FE: Bayesian optimal phase II design with futility and efficacy-stopping boundaries
Xinling Xu, Atsuki Hashimoto, Belay B Yimer, et al.
Climacteric : the Journal of the International Menopause Society
|
June 12, 2024
Phase II study of fezolinetant for treatment of vasomotor symptoms associated with menopause in Japan
Kiyoshi Takamatsu, Takashi Miki, Kentaro Miyazaki, et al.
Climacteric : the Journal of the International Menopause Society
|
May 20, 2026
Patient-reported outcome data from a randomized phase II study (STARLIGHT) of fezolinetant in women in Japan with vasomotor symptoms associated with menopause
Kiyoshi Takamatsu, Takashi Miki, Kentaro Miyazaki, et al.
Dalton Transactions (Cambridge, England : 2003)
|
March 29, 2018
Solvent-free synthesis of monodisperse Cu nanoparticles by thermal decomposition of an oleylamine-coordinated Cu oxalate complex
Takanari Togashi, Masato Nakayama, Atsuki Hashimoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
June 24, 2018
Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan
Hiroshige Mikamo, Kazuhiro Tateda, Katsunori Yanagihara, et al.
Vaccine
|
November 29, 2024
Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naïve Japanese adults: A phase 1 randomized dose-escalation trial
Dorota Borys, Ronald Smulders, Miwa Haranaka, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Journal of Biopharmaceutical Statistics
|
February 19, 2024
A basket trial design based on constrained hierarchical Bayesian model for latent subgroups
Kentaro Takeda, Atsuki Hashimoto, Shufang Liu, et al.
The Journal of Chemical Physics
|
May 27, 2026
Classification of interfacial water governed by water-polymer interactions in hydrated polymers: A molecular dynamics simulation study of ethylene-based and acrylate polymers
Atsuki Hashimoto, Kokoro Shikata, Kang Kim, et al.
Journal of Biopharmaceutical Statistics
|
September 17, 2025
BOP2-FE: Bayesian optimal phase II design with futility and efficacy-stopping boundaries
Xinling Xu, Atsuki Hashimoto, Belay B Yimer, et al.
Climacteric : the Journal of the International Menopause Society
|
June 12, 2024
Phase II study of fezolinetant for treatment of vasomotor symptoms associated with menopause in Japan
Kiyoshi Takamatsu, Takashi Miki, Kentaro Miyazaki, et al.
Climacteric : the Journal of the International Menopause Society
|
May 20, 2026
Patient-reported outcome data from a randomized phase II study (STARLIGHT) of fezolinetant in women in Japan with vasomotor symptoms associated with menopause
Kiyoshi Takamatsu, Takashi Miki, Kentaro Miyazaki, et al.
Dalton Transactions (Cambridge, England : 2003)
|
March 29, 2018
Solvent-free synthesis of monodisperse Cu nanoparticles by thermal decomposition of an oleylamine-coordinated Cu oxalate complex
Takanari Togashi, Masato Nakayama, Atsuki Hashimoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
June 24, 2018
Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan
Hiroshige Mikamo, Kazuhiro Tateda, Katsunori Yanagihara, et al.
Vaccine
|
November 29, 2024
Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naïve Japanese adults: A phase 1 randomized dose-escalation trial
Dorota Borys, Ronald Smulders, Miwa Haranaka, et al.
Page
of 1